ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
TransCode Therapeutics Inc

TransCode Therapeutics Inc (RNAZ)

0.3362
0.0082
(2.50%)
Closed November 20 3:00PM
0.3362
0.00
( 0.00% )
Pre Market: 3:01AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.3362
Bid
0.305
Ask
0.37
Volume
-
0.00 Day's Range 0.00
0.216 52 Week Range 18.664
Market Cap
Previous Close
0.3362
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,724,881
Shares Outstanding
17,265,658
Dividend Yield
-
PE Ratio
-0.32
Earnings Per Share (EPS)
-1.07
Revenue
-
Net Profit
-18.55M

About TransCode Therapeutics Inc

TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regre... TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
TransCode Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAZ. The last closing price for TransCode Therapeutics was US$0.34. Over the last year, TransCode Therapeutics shares have traded in a share price range of US$ 0.216 to US$ 18.664.

TransCode Therapeutics currently has 17,265,658 shares outstanding. The market capitalization of TransCode Therapeutics is US$5.80 million. TransCode Therapeutics has a price to earnings ratio (PE ratio) of -0.32.

RNAZ Latest News

TransCode Therapeutics Open Letter to Shareholders

BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The Board and Management of TransCode Therapeutics (NASDAQ: RNAZ) today issued the following open letter to shareholders of the Company: Dear...

TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance

BOSTON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today...

TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data

The clinical trial Safety Review Committee (SRC) approved opening of Cohort 2 after review of safety data from the three patients comprising Cohort 1No significant safety or dose limiting...

TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology

Patients currently remain on study for continued treatment with TTX-MC138Β Β No significant safety or dose limiting toxicities reportedTTX-MC138, an antisense oligonucleotide conjugated to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0311-8.467193030220.36730.38230.31442002990.33781093CS
4-0.3198-48.750.6560.69690.3134489220.4746579CS
120.058320.97876934150.27790.80.222617248810.48120183CS
26-0.8638-71.98333333331.21.990.21613233870.52688167CS
52-8.8638-96.34565217399.218.6640.21614827712.60123879CS
156-2175.6638-99.9845496324217625040.2161493047211.63349313CS
260-4799.6638-99.9929958333480056000.2161679169852.74521267CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PETWag Group Company
US$ 0.3683
(75.30%)
5.03M
WORXSCWorx Corporation
US$ 1.63
(66.33%)
1.33M
CRKNCrown Electrokinetics Corporation
US$ 1.12
(42.55%)
1.23M
VEEAVeea Inc
US$ 3.78
(34.04%)
823.22k
HPHHighest Performances Holdings Inc
US$ 0.38
(22.66%)
1.53k
PYXSPyxis Oncology Inc
US$ 2.31
(-39.53%)
19.94k
HSTMHealthStream Inc
US$ 20.00
(-36.10%)
102
CACCamden National Corporation
US$ 33.10
(-28.53%)
99
MPBMid Penn Bancorp Inc
US$ 23.205
(-26.22%)
100
BMRCBank of Marin Bancorp
US$ 20.00
(-21.72%)
3
PETWag Group Company
US$ 0.3683
(75.30%)
5.03M
WORXSCWorx Corporation
US$ 1.63
(66.33%)
1.33M
CRKNCrown Electrokinetics Corporation
US$ 1.12
(42.55%)
1.23M
QUBTQuantum Computing Inc
US$ 3.635
(-1.22%)
981.16k
NVDANVIDIA Corporation
US$ 140.70
(-3.56%)
881.33k

RNAZ Discussion

View Posts
MartinLutherKing MartinLutherKing 6 hours ago
And insiders seem to stay away from RNAZ stock as from plague. I did not receive a single response to my 3 emails I sent to Tom and/or IR. Not even acknowledging them or any of my concerns. That is how much a shareholder means to the management. Just to take our money and to vote Yes to approve them using us the same toxic ways. The change is overdue.
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 6 hours ago
There are over 100 studies of the role of miR-10b in at least 18 cancer types over the last 15 years, including some with contributions from our co-founders, making it one of the most studied microRNAs. Studies have shown that an inhibition of miR-10b "prevents the onset of metastasis and eliminate existing metastases, even after treatment has been discontinued." Metastases are responsible for about 90% of all cancer deaths, due to a lack of therapeutics. In Phase 0, a microdose of TTX-MC138 reduced miR-10b by 66%, 24 hours after injection. In another study, MN-anti-miR10b decreased miR-10b by 90% in 24-48 hours, and a 99% downregulation was observed within two weeks. It seems as though this data is quick to ascertain. It's been over two months since the first Phase 1 patients were dosed with 0.4mg/kg of TTX-MC138.

How can the CEO say there can be no assurance that this data will be released?
πŸ‘οΈ0
MetaMonster MetaMonster 13 hours ago
Come to the office Habibi, Fitzgerald it's been so long you've been hiding like a dirty rat scumbag bastard of the the earth you piece of shit
πŸ‘οΈ0
MetaMonster MetaMonster 13 hours ago
Going to make sure an R/S up Fitzgerald ass rat bastard scumbag piece of shit of the earth,
πŸ‘οΈ0
georgie18 georgie18 13 hours ago
You never know is right but always good to when an R/S is on the table...🥳
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 14 hours ago
Monster news can hit the wires A/H or tomorrow morning brothers be on the lookout …
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 14 hours ago
Texas cowboys can pull the trigger at any moment brother
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 15 hours ago
You never know when the texas rattle shake will strike timing is key
πŸ‘οΈ0
georgie18 georgie18 15 hours ago
Did a search on XCUR and your RNAZ post came up...🥳...Don't know if you are aware...

BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The Board and Management of TransCode Therapeutics (NASDAQ: RNAZ) today issued the following open letter to shareholders of the Company:

Dear Shareholders,

At our upcoming Special Meeting to be held November 22, shareholders are being asked to authorize our Board of Directors to effect a reverse split β€” only if the Board determines that doing so is necessary as described below.

Many shareholders rightly ask why this request. Some believe that the potential announcement of additional positive clinical data or other good news will favorably impact our stock price. However, there is no assurance that any good news will occur, will occur by the deadline required, or that the stock will rise after any such positive announcement(s).

A reverse split is NOT something directors or management wishes to do β€” we all hope it won’t be needed. But the Nasdaq Hearings Panel that approved the extension to continue our Nasdaq listing did so on the condition that our shareholders authorize a reverse split β€” should one be necessary. The reverse split will not be necessary if our stock closes at $1.00 per share or more for any ten-day period prior to December 31, 2024.

If our stock does not meet this Nasdaq requirement, and we do not have your vote in favor of the reverse split, Nasdaq will delist our stock. A Nasdaq delisting would in all likelihood have a material adverse effect on the value of our company and the value of your stock.

Our assessment boils down to this: your vote is your decision about whether you support our efforts to maintain our Nasdaq listing. Given our need to raise additional capital as soon as possible to continue the clinical trial and other operations, we believe having our stock remain on Nasdaq is critical to raising the needed capital.

TransCode’s management and directors are unanimously determined to maintain our Nasdaq listing. This is why we need you to authorize the reverse split, with all of us hoping that we will not have to implement this decision.

We call for your understanding and greatly appreciate your support.
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 17 hours ago
The texas rattle snake can strike anytime now… keep your eyes open
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 17 hours ago
Unless the texas rattle snake strikes fda fast track status for the terminally ill cancer patients
πŸ‘οΈ0
tw0122 tw0122 17 hours ago
Technicals oversold look at XCUR today lol. Most penny bios are just daytrades then load them beat down for the biggest gains. Adding .32-.34 until technicals change. Still a chance it goes to .20s again. Anything possible 
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 17 hours ago
All holding, The well is dry
πŸ‘οΈ0
Ms Labonte Ms Labonte 17 hours ago
Fill em bid$$ $weet$$ I got your back$$$$
πŸ‘οΈ0
Ms Labonte Ms Labonte 17 hours ago
Partnership, merger, buyout, junkie$$$$ it’s coming in your face $weet$$$
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 17 hours ago
What do we do brothers , double down or… sell at a loss
πŸ‘οΈ0
Ms Labonte Ms Labonte 17 hours ago
Fill em bid$$ $weet$$ the party is coming$$$
πŸ‘οΈ0
Ms Labonte Ms Labonte 17 hours ago
Who will it be junkie$$$$
Roche. Sales from oncology drugs: $27.82 billion.
Bristol-Myers Squibb. Sales from oncology drugs: $14.71 billion. ...
Johnson & Johnson. Sales from oncology drugs: $14.31 billion. ...
Pfizer. Sales from oncology drugs: $14.03 billion. ...
AstraZeneca. ...
Merck & Co. ...
Novartis. ...
AbbVie. ...
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 2 days ago
It’s a nobel prize with zero value
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 2 days ago
This is a big slap in the face for all the scientific community’s hard work and dedication for the past 20 years,
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 2 days ago
A nobel prize cancer clinical trials with a 5 million dollar market capitalization congratulations to all longs
πŸ‘οΈ0
tw0122 tw0122 2 days ago
Covered short Friday ready to go long some .32s -.34s added so far. When all looks like from and gloom the news eventually follows this month December next year ...its coming patience game now
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 3 days ago
Congrats to all of management, job well done flushing the nobel prize down the toilet
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 3 days ago
We should congratulate Zdravka Medarova
CSO at TransCode Therapeutics for a job well done,
https://informaconnect.com/rna-leaders-usa/speakers/zdravka-medarova/
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 3 days ago
A nobel prize winning technology gone down the drain. Congrats to all longs. congratulations to all of management for a job well done
πŸ‘οΈ0
tapioca tapioca 5 days ago
Back to the .20’s next week?
I’ll probably risk another small buy soon and hope for a bounce.
πŸ‘οΈ0
MetaMonster MetaMonster 5 days ago
Everyone is looking for the rat bastard CEO scam artist Fitzgerald, you want to sabotage the cure to cancer, hunting season is officially open for dirty rats bastards like you who screw investors all their careers while they fill up their pockets and pull the plug master CFO your time is coming you piece of shit for sabotaging the only hope for terminally ill cancer patients
πŸ‘οΈ0
MetaMonster MetaMonster 5 days ago
(857) 837-3099 Answer the phone CEO Fitzgerald everyone wants a piece of you rat bastard,
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
Answer the phone bastard Fitzgerald Keep on hiding rat bastard Fitzgerald everyone is waiting for you piece of shit , the Crack pipe will end up in your ass bastard scumbag fraud artist junkie
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
The rat bastard mother fucker Fitzgerald fucked them all up the ass, There is a line up of investors waiting for him at both offices with proactive investors hunting him down
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
Tom Fitzgerald fucked everyone he knows including his mother, a true scam artist master CFO cooking the books so he can fuck everyone and everything. we all know your sabotage strategy to fill up your pockets and pull the plug on all mother fucker, come to the office Habibi bastard
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 6 days ago
H.C. Wainwright & Co. reiterates RNAZ as a Buy, and maintains its $3 PT.
3) A RS "will not be necessary if our stock closes at $1.00 per share or more for any ten-day period prior to December 31, 2024."
4) There are 11.24M warrants at $1.22, for a total of $13.7M in funding, and another 357K at $1.525 for $543.7K.
5) On Jan. 18, 2025, another batch of 500K warrants at $0.375 become exercisable for $187.5K in funding.
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 6 days ago
The "doctors" at RNAZ, along with their partners/MMs/friends/family, can turn this thing around without a ratification/RS/offering, or they can face delisting, bankruptcy or a buyout. If I were Tom, I'd be on the phone nonstop, or does he not know anyone who believes in them?
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
Shareholders want to make sure you get a baseball bat up the ass for your virtual video fucking investors all your career you mother fucker rat bastard scum of the earth
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
Come out of your rat hole Fitzgerald and face the shareholders waiting for you in front of the office you bastard, You like fucking investors all your career, now shareholders have bonus plan for you rat bastard mother fucker
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
Collapse this piece of garage so you can sabotage the cure to cancer, you can all burn in hell you bastards, Fitzgerald filled up his pockets and is ready to pull the plug on all
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
Let Fitzgerald and all his bastards lab rats pull the plug and burn this big piece of shit cancer hoax to the ground in hell where they all belong
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
Go Fitzgerald go bankrupt this piece of shit company funnel the rest of the money in your pockets and run for your life you dirty rat piece of shit bastard of the earth
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
The world knows your a crack head junkie bastard cook the books master CFO scam artist of the Nasdaq Fitzgerald, burn it to the ground in hell where you belong
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
The rat Fitzgerald needs more money for his crack pipe, the junkie rat scam fraudster stole his mom's purse at the rehab center,
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
Nope, the rat Fitzgerald and his lab rats are ready to sabotage and run this billion dollar company to the ground, cook the books with master rat bastard Fitzgerald expertise and pocket all investors money and sell patients under the table to big pharma for big cash under the table
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 6 days ago
ALL of our partnerships? What is BRAIN/Akribion paying us??? Can we learn who our "undisclosed" and "in discussion" partners are? Or, how about some secondary efficacy results from Ph1, or, heck, how about letting us know where PH0 results stand?
πŸ‘οΈ0
Here Today Here Today 6 days ago
That's why I voted NO to all 3 proposals!!!

Management needs to be mindful of the money and work hard to get more - Not just reverse split every single time they deem necessary.
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 6 days ago
Management have no respect for shareholders and it shows,
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 6 days ago
From the boston ghetto, He needs to be thought a lesson
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 6 days ago
At the moment of glory.. they shatter everyone’s dream to the promise land, Not good ceo not good at all for you and your family
πŸ‘οΈ0
MartinLutherKing MartinLutherKing 6 days ago
Produce or delist.. how many times do you have to take shareholders to the cleaners, An accountant by profession a specialist on how to cook the books. Shame on you
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
Could would should Fitzgerald strikes again, Go bankrupt pull the plug and collapse this empty shell to the ground in hell where he belongs
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
That's because Fitzgerald smokes the crack pipe with street hookers, a full blown crack head junkie bastard would screw your mom for a dollar, pull the plug and go fuck yourself you rat bastard
πŸ‘οΈ0
MetaMonster MetaMonster 6 days ago
Fitzgerald the world knows your a piece of shit rat bastard that would would steal your mom's purse in rehab you fucken cunt
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock